Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients

OBJECTIVE: This prospective, post-marketing study collected sunitinib safety and efficacy data in Japanese patients with unresectable/metastatic renal cell carcinoma. Retrospective analysis investigated adverse events as potential sunitinib efficacy biomarkers. METHODS: Patients administered sunitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaza, Hideyuki, Naito, Seiji, Ueno, Naomi, Aoki, Kouji, Houzawa, Hiroyuki, Pitman Lowenthal, Susan, Lee, Sang-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461239/
https://www.ncbi.nlm.nih.gov/pubmed/25917359
http://dx.doi.org/10.1093/jjco/hyv045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461239/
https://www.ncbi.nlm.nih.gov/pubmed/25917359
http://dx.doi.org/10.1093/jjco/hyv045

Ejemplares similares